Search Results
Gareth Morgan | ESH MM 2019 | The impact of "double-hit" genetics on patient outcomes in MM
Dr. Gareth Morgan Discusses Gene Expression Profiling for Smoldering Myeloma Patients
What is Double Hit Lymphoma? - ICML 2019
ASH 2019: Double Hit Myeloma | Dr. Martin Kaiser
Prof. Gareth J Morgan | ASH 2017 | Novel oncogenes and tumor suppressor genes in NDMM
ASH 2019: New Drugs Targeting BCMA — Immunotherapy for Myeloma | Dr. Gareth Morgan
The future of multiple myeloma treatment
Structural variants in multiple myeloma: impact on outcomes & potential drug targets
Identifying the drivers of multiple myeloma
Dr. Morgan on the Future of Myeloma Treatment
Double-Sized, Double Hit Diffuse Large B-Cell Lymphoma
Nico Gagelmann | EBMT 2019 | Outcomes of patients with high-risk cytogenetics undergoing SCT in MM